Sergio Serrano-Villar

Cited by

	All	Since 2020
Citations	5622	3777
h-index	34	30
i10-index	86	68

820

410

205

615

201320142015201620172018201920202021202220232024202515 108 195 313 337 360 425 621 801 797 664 720 150

Public access

View all

84 articles

10 articles

available

not available

Based on funding mandates

Co-authors

Santiago MorenoHospital Ramón y Cajal, University of Alcala, MadridVerified email at salud.madrid.org
Vicente EstradaHospital Clinico San CarlosVerified email at salud.madrid.org
Javier Martínez-SanzInfectious Diseases Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.Verified email at salud.madrid.org
Jose A. Perez-MolinaNational Reference Center Tropical Imported Infections. ID Department. Hospital Universitario RamónVerified email at salud.madrid.org
Andres MoyaProfessor of Genetics, University of ValènciaVerified email at uv.es
Alejandro VallejoInvestigador Titular, Instituto Ramón y Cajal de Investigación Sanitaria (IRyCIS), HospitalVerified email at salud.madrid.org
Mª Ángeles Muñoz-FernándezHospital General Universitario Gregorio MarañónVerified email at salud.madrid.org
Matilde Sanchez CondeRamón y Cajal MadridVerified email at salud.madrid.org
Steven G. DeeksUniversity of California, San FranciscoVerified email at ucsf.edu
Coral BarbasUniversidad San Pablo-CEUVerified email at ceu.es
Jorge F. Vázquez-CastellanosPostdoctoral Scientist, VIB - KU LeuvenVerified email at kuleuven.vib.be
Alfonso Muriel (https://orcid.org/0000-0...Hospital Universitario Ramon y Cajal (RoR:050eq1942). Universidad de Alcalá (RoR: 04pmn0e78)Verified email at uah.es
Peter HuntUniversity of California San FranciscoVerified email at php.ucsf.edu
Javier ZamoraHead of Clinical Biostatistics Unit. Hospital Ramon y Cajal (IRYCIS). CIBERESPVerified email at salud.madrid.org
Amparo LatorreProfessor of Genetics, University of ValenciaVerified email at uv.es
Manuel FerrerInvestigador CientíficoVerified email at icp.csic.es
Alba Talavera-RodríguezInfectious Diseases Department IRYCIS (Ramón y Cajal Health Research Institute)Verified email at salud.madrid.org
Joseph M. McCuneProfessor of Medicine, University of California, San FranciscoVerified email at ucsf.edu
Félix Gutiérrez RoderoHospital Universitario de Elche & Universidad Miguel Hernández, Alicante, SpainVerified email at gva.es
Jana SeifertUniversity of HohenheimVerified email at uni-hohenheim.de

Sergio Serrano-Villar

Hospital Universitario Ramón y Cajal, Madrid

Verified email at salud.madrid.org

HIV infection Infectious Diseases Microbiome


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk … S Serrano-Villar, T Sainz, SA Lee, PW Hunt, E Sinclair, BL Shacklett, ... PLoS pathogens 10 (5), e1004078, 2014	703	2014
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort P Vizcarra, MJ Pérez-Elías, C Quereda, A Moreno, MJ Vivancos, ... The lancet HIV 7 (8), e554-e564, 2020	443	2020
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals JF Vázquez-Castellanos, S Serrano-Villar, A Latorre, A Artacho, ... Mucosal immunology 8 (4), 760-772, 2015	307	2015
Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio S Serrano-Villar, MJ Pérez-Elías, F Dronda, JL Casado, A Moreno, ... PloS one 9 (1), e85798, 2014	266	2014
Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy C Gutiérrez, S Serrano-Villar, N Madrid-Elena, MJ Pérez-Elías, ME Martín, ... Aids 30 (9), 1385-1392, 2016	248	2016
The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults T Sainz, S Serrano-Villar, L Díaz, MIG Tomé, MD Gurbindo, MI de José, ... Aids 27 (9), 1513-1516, 2013	198	2013
The CD 4: CD 8 ratio is associated with markers of age‐associated disease in virally suppressed HIV‐infected patients with immunological recovery S Serrano‐Villar, S Moreno, M Fuentes‐Ferrer, C Sánchez‐Marcos, ... HIV medicine 15 (1), 40-49, 2014	194	2014
The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression S Serrano-Villar, C Gutiérrez, A Vallejo, B Hernandez-Novoa, L Díaz, ... Journal of Infection 66 (1), 57-66, 2013	181	2013
The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects S Serrano-Villar, JF Vázquez-Castellanos, A Vallejo, A Latorre, T Sainz, ... Mucosal immunology 10 (5), 1279-1293, 2017	138	2017
IL-15 promotes activation and expansion of CD8⁺ T cells in HIV-1 infection SA Younes, ML Freeman, JC Mudd, CL Shive, A Reynaldi, S Panigrahi, ... The Journal of clinical investigation 126 (7), 2745-2756, 2016	124	2016
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study J Martínez-Sanz, A Muriel, R Ron, S Herrera, JA Pérez-Molina, S Moreno, ... Clinical Microbiology and Infection 27 (2), 238-243, 2021	115	2021
Gut bacteria metabolism impacts immune recovery in HIV-infected individuals S Serrano-Villar, D Rojo, M Martínez-Martínez, S Deusch, ... EBioMedicine 8, 203-216, 2016	115	2016
Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients I Iturrieta-Zuazo, CG Rita, A García-Soidán, A de Malet Pintos-Fonseca, ... Clinical immunology 219, 108572, 2020	113	2020
Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers OM Moreno‐Arrones, S Serrano‐Villar, V Perez‐Brocal, ... Journal of the European Academy of Dermatology and Venereology 34 (2), 400-405, 2020	111	2020
The impact of human immunodeficiency virus infection on gut microbiota α-diversity: an individual-level meta-analysis SA Tuddenham, WLA Koay, N Zhao, JR White, KG Ghanem, CL Sears Clinical Infectious Diseases 70 (4), 615-627, 2020	101	2020
Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis JRP Pardo, SS Villar, JCR Ramos, V Pintado Enfermedades infecciosas y microbiologia clinica 32, 41-48, 2014	85	2014
Fecal microbiota transplantation in HIV: A pilot placebo-controlled study S Serrano-Villar, A Talavera-Rodríguez, MJ Gosalbes, N Madrid, ... Nature Communications 12 (1), 1139, 2021	83	2021
Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men A Goren, CG Wambier, S Herrera, J McCoy, S Vaño‐Galván, F Gioia, ... Journal of the European Academy of Dermatology and Venereology 35 (1), e13, 2020	74	2020
Smoking cessation in HIV patients: rate of success and associated factors M Fuster, V Estrada, MC Fernandez‐Pinilla, ME Fuentes‐Ferrer, ... HIV medicine 10 (10), 614-619, 2009	71	2009
Human immunodeficiency virus as a chronic disease: evaluation and management of nonacquired immune deficiency syndrome-defining conditions S Serrano-Villar, F Gutiérrez, C Miralles, J Berenguer, A Rivero, ... Open Forum Infectious Diseases 3 (2), ofw097, 2016	68	2016

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors